Detalhe da pesquisa
1.
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.
Br J Haematol
; 168(4): 507-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25302557
2.
Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy.
Br J Haematol
; 184(3): 440-443, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363736
3.
[11 C]Methionine emerges as a new biomarker for tracking active myeloma lesions.
Br J Haematol
; 181(5): 701-703, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28466502
4.
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing.
Haematologica
; 103(11): e544-e548, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954938
5.
Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia.
Br J Haematol
; 169(3): 445-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25382417
6.
Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab ("Pom-PAD-Dara") in relapsed/refractory multiple myeloma.
Cancer Med
; 9(16): 5819-5826, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32608149